ID   GBRB3_RAT               Reviewed;         473 AA.
AC   P63079; P15433;
DT   13-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 1.
DT   02-OCT-2024, entry version 151.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit beta-3 {ECO:0000303|PubMed:2540033};
DE   AltName: Full=GABA(A) receptor subunit beta-3 {ECO:0000303|PubMed:11528422};
DE            Short=GABAAR subunit beta-3 {ECO:0000303|PubMed:9882711};
DE   Flags: Precursor;
GN   Name=Gabrb3 {ECO:0000312|RGD:2651}; Synonyms=Gabrb-3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RC   TISSUE=Brain;
RX   PubMed=2548852; DOI=10.1002/j.1460-2075.1989.tb03557.x;
RA   Ymer S., Schofield P.R., Draguhn A., Werner P., Koehler M., Seeburg P.H.;
RT   "GABAA receptor beta subunit heterogeneity: functional expression of cloned
RT   cDNAs.";
RL   EMBO J. 8:1665-1670(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR
RP   LOCATION, AND SUBUNIT.
RX   PubMed=2540033; DOI=10.1016/0014-5793(89)80271-6;
RA   Lolait S.J., O'Carroll A.-M., Kusano K., Muller J.-M., Brownstein M.J.,
RA   Mahan L.C.;
RT   "Cloning and expression of a novel rat GABAA receptor.";
RL   FEBS Lett. 246:145-148(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-80.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=8382702; DOI=10.1016/s0021-9258(18)53626-7;
RA   Kirkness E.F., Fraser C.M.;
RT   "A strong promoter element is located between alternative exons of a gene
RT   encoding the human gamma-aminobutyric acid-type A receptor beta 3 subunit
RT   (GABRB3).";
RL   J. Biol. Chem. 268:4420-4428(1993).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=9092594; DOI=10.1523/jneurosci.17-08-02728.1997;
RA   Tretter V., Ehya N., Fuchs K., Sieghart W.;
RT   "Stoichiometry and assembly of a recombinant GABAA receptor subtype.";
RL   J. Neurosci. 17:2728-2737(1997).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9464994; DOI=10.1523/jneurosci.18-05-01693.1998;
RA   Nusser Z., Sieghart W., Somogyi P.;
RT   "Segregation of different GABAA receptors to synaptic and extrasynaptic
RT   membranes of cerebellar granule cells.";
RL   J. Neurosci. 18:1693-1703(1998).
RN   [6]
RP   FUNCTION, TRANSPORTER ACTIVITY, ACTIVITY REGULATION, AND INTERACTION WITH
RP   GABRA1 AND GABRE.
RX   PubMed=9882711; DOI=10.1124/mol.55.1.168;
RA   Neelands T.R., Fisher J.L., Bianchi M., Macdonald R.L.;
RT   "Spontaneous and gamma-aminobutyric acid (GABA)-activated GABA(A) receptor
RT   channels formed by epsilon subunit-containing isoforms.";
RL   Mol. Pharmacol. 55:168-178(1999).
RN   [7]
RP   FUNCTION, TRANSPORTER ACTIVITY, ACTIVITY REGULATION, TISSUE SPECIFICITY,
RP   AND INTERACTION WITH GABRA5; GABRG3 AND GABRP.
RX   PubMed=10462548; DOI=10.1124/mol.56.3.598;
RA   Neelands T.R., Macdonald R.L.;
RT   "Incorporation of the pi subunit into functional gamma-aminobutyric Acid(A)
RT   receptors.";
RL   Mol. Pharmacol. 56:598-610(1999).
RN   [8]
RP   INTERACTION WITH UBQLN1.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RX   PubMed=11528422; DOI=10.1038/nn0901-908;
RA   Bedford F.K., Kittler J.T., Muller E., Thomas P., Uren J.M., Merlo D.,
RA   Wisden W., Triller A., Smart T.G., Moss S.J.;
RT   "GABA(A) receptor cell surface number and subunit stability are regulated
RT   by the ubiquitin-like protein Plic-1.";
RL   Nat. Neurosci. 4:908-916(2001).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [10]
RP   INTERACTION WITH GIT1.
RX   PubMed=25284783; DOI=10.1016/j.celrep.2014.08.061;
RA   Smith K.R., Davenport E.C., Wei J., Li X., Pathania M., Vaccaro V., Yan Z.,
RA   Kittler J.T.;
RT   "GIT1 and betaPIX are essential for GABA(A) receptor synaptic stability and
RT   inhibitory neurotransmission.";
RL   Cell Rep. 9:298-310(2014).
RN   [11]
RP   INTERACTION WITH KIF21B, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=25172774; DOI=10.1016/j.ejcb.2014.07.007;
RA   Labonte D., Thies E., Kneussel M.;
RT   "The kinesin KIF21B participates in the cell surface delivery of gamma2
RT   subunit-containing GABAA receptors.";
RL   Eur. J. Cell Biol. 93:338-346(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN A COMPLEX WITH
RP   NLGN2; GABRA1; GABRB2; GABRG2 AND GABRB3.
RX   PubMed=28279354; DOI=10.1016/j.neuron.2017.02.023;
RA   Yamasaki T., Hoyos-Ramirez E., Martenson J.S., Morimoto-Tomita M.,
RA   Tomita S.;
RT   "GARLH family proteins stabilize GABAA receptors at synapses.";
RL   Neuron 93:1138-1152(2017).
CC   -!- FUNCTION: Beta subunit of the heteropentameric ligand-gated chloride
CC       channel gated by gamma-aminobutyric acid (GABA), a major inhibitory
CC       neurotransmitter in the brain (PubMed:10462548, PubMed:2540033,
CC       PubMed:2548852, PubMed:9882711). GABA-gated chloride channels, also
CC       named GABA(A) receptors (GABAAR), consist of five subunits arranged
CC       around a central pore and contain GABA active binding site(s) located
CC       at the alpha and beta subunit interface(s) (PubMed:9092594). GABAARs
CC       containing beta-3/GABRB3 subunit are found at both synaptic and
CC       extrasynaptic sites (PubMed:9464994). When activated by GABA, GABAARs
CC       selectively allow the flow of chloride anions across the cell membrane
CC       down their electrochemical gradient (PubMed:10462548, PubMed:2540033,
CC       PubMed:9882711). Chloride influx into the postsynaptic neuron following
CC       GABAAR opening decreases the neuron ability to generate a new action
CC       potential, thereby reducing nerve transmission (PubMed:2540033).
CC       GABAARs containing alpha-1 and beta-3 subunits exhibit synaptogenic
CC       activity; the gamma-2 subunit being necessary but not sufficient to
CC       induce rapid synaptic contacts formation (By similarity). Extrasynaptic
CC       beta-3 receptors contribute to the tonic GABAergic inhibition
CC       (PubMed:9464994). GABAARs containing alpha-1, beta-3 and epsilon
CC       subunits may permit spontaneous chloride channel activity while
CC       preserving the structural information required for GABA-gated openings
CC       (PubMed:9882711). Beta-containing GABAARs can simultaneously bind GABA
CC       and histamine where histamine binds at the interface of two neighboring
CC       beta subunits, which may be involved in the regulation of sleep and
CC       wakefulness (By similarity). Plays an important role in somatosensation
CC       and in the production of antinociception (By similarity).
CC       {ECO:0000250|UniProtKB:P28472, ECO:0000250|UniProtKB:P63080,
CC       ECO:0000269|PubMed:10462548, ECO:0000269|PubMed:2540033,
CC       ECO:0000269|PubMed:2548852, ECO:0000269|PubMed:9092594,
CC       ECO:0000269|PubMed:9464994, ECO:0000269|PubMed:9882711}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chloride(in) = chloride(out); Xref=Rhea:RHEA:29823,
CC         ChEBI:CHEBI:17996; Evidence={ECO:0000269|PubMed:10462548,
CC         ECO:0000269|PubMed:2540033, ECO:0000269|PubMed:9882711};
CC   -!- ACTIVITY REGULATION: Potentiated by pentobarbital, loreclezole and
CC       alphaxalone (PubMed:10462548, PubMed:9882711). Potentiated by histamine
CC       (By similarity). Allosterically inhibited by pregnenolone sulfate
CC       (PubMed:10462548). Inhibited by zinc and furosemide (PubMed:10462548,
CC       PubMed:9882711). Beta-3-containing GABAAR are potentiated by lanthanum
CC       when associated with alpha-1 subunit and inhibited by lanthanum when
CC       associated with alpha-5 subunit (PubMed:10462548, PubMed:9882711).
CC       {ECO:0000250|UniProtKB:P28472, ECO:0000269|PubMed:10462548,
CC       ECO:0000269|PubMed:9882711}.
CC   -!- SUBUNIT: Heteropentamer, formed by a combination of alpha (GABRA1-6),
CC       beta (GABRB1-3), gamma (GABRG1-3), delta (GABRD), epsilon (GABRE), rho
CC       (GABRR1-3), pi (GABRP) and theta (GABRQ) chains, each subunit
CC       exhibiting distinct physiological and pharmacological properties
CC       (PubMed:10462548, PubMed:2540033, PubMed:2548852, PubMed:9092594,
CC       PubMed:9882711). Can form functional homopentamers (in vitro) (By
CC       similarity). Interacts with UBQLN1 (PubMed:11528422). May interact with
CC       KIF21B (PubMed:25172774). Identified in a complex of 720 kDa composed
CC       of LHFPL4, NLGN2, GABRA1, GABRB2, GABRG2 and GABRB3 (PubMed:28279354).
CC       Interacts with LHFPL4 (By similarity). Interacts with GIT1; this
CC       interaction is required for synaptic GABRB3 surface stability and
CC       inhibitory synapse strength (PubMed:25284783).
CC       {ECO:0000250|UniProtKB:P28472, ECO:0000250|UniProtKB:P63080,
CC       ECO:0000269|PubMed:10462548, ECO:0000269|PubMed:11528422,
CC       ECO:0000269|PubMed:25172774, ECO:0000269|PubMed:25284783,
CC       ECO:0000269|PubMed:2540033, ECO:0000269|PubMed:2548852,
CC       ECO:0000269|PubMed:28279354, ECO:0000269|PubMed:9092594,
CC       ECO:0000269|PubMed:9882711}.
CC   -!- INTERACTION:
CC       P63079; Q7TSU1: Arfgef2; NbExp=3; IntAct=EBI-6257937, EBI-6257913;
CC   -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane
CC       {ECO:0000269|PubMed:9464994}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P28472}. Cell membrane
CC       {ECO:0000269|PubMed:2540033, ECO:0000269|PubMed:2548852,
CC       ECO:0000269|PubMed:9092594, ECO:0000269|PubMed:9464994}; Multi-pass
CC       membrane protein {ECO:0000250|UniProtKB:P28472}. Cytoplasmic vesicle
CC       membrane {ECO:0000269|PubMed:25172774}. Note=The beta-3 subunits are
CC       present in Golgi synapses and on the extrasynaptic membranes (when
CC       coassembled with alpha-1/6 and gamma-2 subunits), and in some of the
CC       mossy fiber to granule cell synapses (when coassembled with alpha-6 and
CC       gamma-2 subunits) (PubMed:9464994). The beta-3 subunits, when
CC       coassembled with alpha-6 and delta subunits, are found only on the
CC       extrasynaptic somatic and dendritic membranes (PubMed:9464994).
CC       {ECO:0000269|PubMed:9464994}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain (at protein level), in
CC       cerebellar granule cells. {ECO:0000269|PubMed:25172774,
CC       ECO:0000269|PubMed:9464994}.
CC   -!- DOMAIN: GABAARs subunits share a common topological structure: a
CC       peptide sequence made up of a long extracellular N-terminal, four
CC       transmembrane domains, intracellular or cytoplasmic domain located
CC       between the third and the fourth transmembrane domains.
CC       {ECO:0000250|UniProtKB:P28472}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9) family.
CC       Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily. GABRB3 sub-
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X15468; CAA33495.1; -; mRNA.
DR   EMBL; L04310; AAA41180.1; -; Genomic_DNA.
DR   PIR; S04466; S04466.
DR   RefSeq; NP_058761.1; NM_017065.1.
DR   AlphaFoldDB; P63079; -.
DR   SMR; P63079; -.
DR   ComplexPortal; CPX-280; GABA-A receptor, alpha-4/beta-3/delta.
DR   ComplexPortal; CPX-405; GABA-A receptor, alpha6-beta3-gamma2.
DR   ComplexPortal; CPX-406; GABA-A receptor, alpha6-beta3-delta.
DR   ComplexPortal; CPX-409; GABA-A receptor, alpha3-beta3-gamma2.
DR   ComplexPortal; CPX-410; GABA-A receptor, alpha1-beta3-gamma2.
DR   ComplexPortal; CPX-411; GABA-A receptor, alpha5-beta3-gamma2.
DR   ComplexPortal; CPX-412; GABA-A receptor, alpha2-beta3-gamma2.
DR   CORUM; P63079; -.
DR   DIP; DIP-60770N; -.
DR   IntAct; P63079; 5.
DR   STRING; 10116.ENSRNOP00000071478; -.
DR   BindingDB; P63079; -.
DR   ChEMBL; CHEMBL2111374; -.
DR   ChEMBL; CHEMBL3883322; -.
DR   ChEMBL; CHEMBL4296047; -.
DR   ChEMBL; CHEMBL4296048; -.
DR   ChEMBL; CHEMBL4296049; -.
DR   ChEMBL; CHEMBL4296050; -.
DR   ChEMBL; CHEMBL4296051; -.
DR   ChEMBL; CHEMBL4296052; -.
DR   ChEMBL; CHEMBL4296053; -.
DR   ChEMBL; CHEMBL4296054; -.
DR   ChEMBL; CHEMBL4296060; -.
DR   ChEMBL; CHEMBL4296061; -.
DR   ChEMBL; CHEMBL4296062; -.
DR   ChEMBL; CHEMBL5291947; -.
DR   ChEMBL; CHEMBL5291948; -.
DR   ChEMBL; CHEMBL5291950; -.
DR   DrugCentral; P63079; -.
DR   GlyCosmos; P63079; 3 sites, No reported glycans.
DR   GlyGen; P63079; 3 sites, 1 N-linked glycan (1 site).
DR   iPTMnet; P63079; -.
DR   PhosphoSitePlus; P63079; -.
DR   PaxDb; 10116-ENSRNOP00000061969; -.
DR   ABCD; P63079; 2 sequenced antibodies.
DR   Ensembl; ENSRNOT00000113752.1; ENSRNOP00000085111.1; ENSRNOG00000060599.2.
DR   Ensembl; ENSRNOT00055025431; ENSRNOP00055020756; ENSRNOG00055014837.
DR   Ensembl; ENSRNOT00060000138; ENSRNOP00060000084; ENSRNOG00060000098.
DR   Ensembl; ENSRNOT00065005454; ENSRNOP00065003981; ENSRNOG00065003735.
DR   GeneID; 24922; -.
DR   KEGG; rno:24922; -.
DR   UCSC; RGD:2651; rat.
DR   AGR; RGD:2651; -.
DR   CTD; 2562; -.
DR   RGD; 2651; Gabrb3.
DR   eggNOG; KOG3643; Eukaryota.
DR   GeneTree; ENSGT00940000154713; -.
DR   InParanoid; P63079; -.
DR   OrthoDB; 4265336at2759; -.
DR   PhylomeDB; P63079; -.
DR   Reactome; R-RNO-977443; GABA receptor activation.
DR   PRO; PR:P63079; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:1902711; C:GABA-A receptor complex; IPI:ComplexPortal.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0060077; C:inhibitory synapse; IDA:MGI.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:1902495; C:transmembrane transporter complex; IBA:GO_Central.
DR   GO; GO:0035612; F:AP-2 adaptor complex binding; IPI:RGD.
DR   GO; GO:0005254; F:chloride channel activity; IDA:RGD.
DR   GO; GO:0004890; F:GABA-A receptor activity; IDA:UniProtKB.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0005216; F:monoatomic ion channel activity; ISO:RGD.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0007420; P:brain development; ISO:RGD.
DR   GO; GO:0071420; P:cellular response to histamine; ISS:UniProtKB.
DR   GO; GO:0071294; P:cellular response to zinc ion; ISO:RGD.
DR   GO; GO:0021549; P:cerebellum development; ISO:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0099565; P:chemical synaptic transmission, postsynaptic; ISO:RGD.
DR   GO; GO:1902476; P:chloride transmembrane transport; ISO:RGD.
DR   GO; GO:0042747; P:circadian sleep/wake cycle, REM sleep; ISO:RGD.
DR   GO; GO:0090102; P:cochlea development; ISO:RGD.
DR   GO; GO:0035640; P:exploration behavior; ISO:RGD.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060022; P:hard palate development; ISO:RGD.
DR   GO; GO:0060080; P:inhibitory postsynaptic potential; ISO:RGD.
DR   GO; GO:1904862; P:inhibitory synapse assembly; ISS:UniProtKB.
DR   GO; GO:0060119; P:inner ear receptor cell development; ISO:RGD.
DR   GO; GO:0060384; P:innervation; ISO:RGD.
DR   GO; GO:0007612; P:learning; ISO:RGD.
DR   GO; GO:0007613; P:memory; ISO:RGD.
DR   GO; GO:0034220; P:monoatomic ion transmembrane transport; ISO:RGD.
DR   GO; GO:0061744; P:motor behavior; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; ISO:RGD.
DR   GO; GO:0048666; P:neuron development; ISO:RGD.
DR   GO; GO:0060078; P:regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0019098; P:reproductive behavior; ISO:RGD.
DR   GO; GO:0072347; P:response to anesthetic; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0060021; P:roof of mouth development; ISS:UniProtKB.
DR   GO; GO:0035176; P:social behavior; ISO:RGD.
DR   GO; GO:0051932; P:synaptic transmission, GABAergic; IDA:RGD.
DR   CDD; cd18999; LGIC_ECD_GABAAR_B; 1.
DR   CDD; cd19053; LGIC_TM_GABAAR_beta; 1.
DR   Gene3D; 2.70.170.10; Neurotransmitter-gated ion-channel ligand-binding domain; 1.
DR   Gene3D; 1.20.58.390; Neurotransmitter-gated ion-channel transmembrane domain; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR002289; GABAAb_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR038050; Neuro_actylchol_rec.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   NCBIfam; TIGR00860; LIC; 1.
DR   PANTHER; PTHR18945:SF571; GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT BETA-3; 1.
DR   PANTHER; PTHR18945; NEUROTRANSMITTER GATED ION CHANNEL; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01160; GABAARBETA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF90112; Neurotransmitter-gated ion-channel transmembrane pore; 1.
DR   SUPFAM; SSF63712; Nicotinic receptor ligand binding domain-like; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Chloride; Chloride channel; Cytoplasmic vesicle;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..473
FT                   /note="Gamma-aminobutyric acid receptor subunit beta-3"
FT                   /id="PRO_0000000464"
FT   TOPO_DOM        26..246
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P28472"
FT   TRANSMEM        247..267
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P28472"
FT   TOPO_DOM        268..271
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P28472"
FT   TRANSMEM        272..292
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P28472"
FT   TOPO_DOM        293..304
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P28472"
FT   TRANSMEM        305..328
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P28472"
FT   TOPO_DOM        329..447
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P28472"
FT   TRANSMEM        448..470
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P28472"
FT   TOPO_DOM        471..473
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   BINDING         122
FT                   /ligand="histamine"
FT                   /ligand_id="ChEBI:CHEBI:58432"
FT                   /ligand_note="ligand shared between two neighboring beta
FT                   subunits"
FT                   /note="in chain B"
FT                   /evidence="ECO:0000250|UniProtKB:P28472"
FT   BINDING         180
FT                   /ligand="4-aminobutanoate"
FT                   /ligand_id="ChEBI:CHEBI:59888"
FT                   /ligand_note="ligand shared with the neighboring alpha
FT                   subunit"
FT                   /note="in chain A"
FT                   /evidence="ECO:0000250|UniProtKB:P28472"
FT   BINDING         181..182
FT                   /ligand="histamine"
FT                   /ligand_id="ChEBI:CHEBI:58432"
FT                   /ligand_note="ligand shared between two neighboring beta
FT                   subunits"
FT                   /note="in chain B"
FT                   /evidence="ECO:0000250|UniProtKB:P28472"
FT   BINDING         182
FT                   /ligand="4-aminobutanoate"
FT                   /ligand_id="ChEBI:CHEBI:59888"
FT                   /ligand_note="ligand shared with the neighboring alpha
FT                   subunit"
FT                   /note="in chain A"
FT                   /evidence="ECO:0000250|UniProtKB:P28472"
FT   BINDING         227
FT                   /ligand="4-aminobutanoate"
FT                   /ligand_id="ChEBI:CHEBI:59888"
FT                   /ligand_note="ligand shared with the neighboring alpha
FT                   subunit"
FT                   /note="in chain A"
FT                   /evidence="ECO:0000250|UniProtKB:P28472"
FT   BINDING         227
FT                   /ligand="histamine"
FT                   /ligand_id="ChEBI:CHEBI:58432"
FT                   /ligand_note="ligand shared between two neighboring beta
FT                   subunits"
FT                   /note="in chain B"
FT                   /evidence="ECO:0000250|UniProtKB:P28472"
FT   CARBOHYD        33
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        105
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        174
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        161..175
FT                   /evidence="ECO:0000250|UniProtKB:P28472"
FT   CONFLICT        256
FT                   /note="L -> M (in Ref. 1; CAA33495)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   473 AA;  54166 MW;  6A5ABD8A9143FE45 CRC64;
     MWGFAGGRLF GIFSAPVLVA VVCCAQSVND PGNMSFVKET VDKLLKGYDI RLRPDFGGPP
     VCVGMNIDIA SIDMVSEVNM DYTLTMYFQQ YWRDKRLAYS GIPLNLTLDN RVADQLWVPD
     TYFLNDKKSF VHGVTVKNRM IRLHPDGTVL YGLRITTTAA CMMDLRRYPL DEQNCTLEIE
     SYGYTTDDIE FYWRGGDKAV TGVERIELPQ FSIVEHRLVS RNVVFATGAY PRLSLSFRLK
     RNIGYFILQT YMPSILITIL SWVSFWINYD ASAARVALGI TTVLTMTTIN THLRETLPKI
     PYVKAIDMYL MGCFVFVFLA LLEYAFVNYI FFGRGPQRQK KLAEKTAKAK NDRSKSEINR
     VDAHGNILLA PMDVHNEMNE VAGSVGDTRN SAISFDNSGI QYRKQSMPKE GHGRYMGDRS
     IPHKKTHLRR RSSQLKIKIP DLTDVNAIDR WSRIVFPFTF SLFNLVYWLY YVN
//
